Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2006.421 | A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2 Study to Investigate Pharmacodynamics, Safety, Tolerability and Parmacokinetics of RO5073031 in Patients with Type 2 Diabetes Mellitus Treated with a Stable Dose of Metformin | Prof. Kong P.S. Alice |
| 2006.420 | A Clinical Evaluation of the XIENCE | Prof. Chan Wai Man Wilson |
| 2006.419 | Neutrophil Activation Program Induced by Bacterial Lipopolysaccharde in Preterm, Term Infants and Adults | Prof. Ng Pak Cheung |
| 2006.418 | A Multi-Centre, Randomised, Double-Blind, Placebo- and Entacapone-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson | Prof. Mok C.T. Vincent |
| 2006.417 | Functional, Clinical & Radiological Outcome of Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Control Clinical Trial Studies Comparing Bone Patella Bone, Single Bundle and Double Bundle Method | Dr. Chan Kai Ming |
| 2006.415 | Intermittent Versus Continuous Erlotinib With Concomitant Modified | Prof. Ma B.Y. Brigette |
| 2006.414 | A Randomized, Double-Blind, Parallel Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Moderately Emetogenic Chemotherapy | Prof. Yeo Winnie |
| 2006.413 | Portable Chest Radiography in ICU: Dose Synchronizing with End-Inspiration Affect Clinical Management? | Dr. Tang Kin Bong Wilson |
| 2006.411 | Long Term Neurocognitive Effects in Children Exposed to Low Dose Prenatal Methylmercury Exposure | Dr. Lam Hugh Simon Hung San |
| 2006.407 | Do An Education Programme and Telephone Follow up have Additional Value to Usual Service? A Pilot Study | Ms. Lai Yeuk Yan Carmen |
| 2006.404 | Evaluation of New Diagnostic and Treatment Algorithm for Obstructive Sleep Apnea in High Risk Population in Hong Kong | Dr. To Kin Wang |
| 2006.401 | Comparison of Two-Exit-Site Care Methods, Film Dressing (F) Method and Simple Gauze Dressing (G) Method, in Chronic Peritoneal Dialysis (CPD) Patients | Ms. Law Man Ching |
| 2006.400 | A 54-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Acetycholinesterase Inhibitors on Cognition and Overall Clinical Response in APOEe4-Stratified Subjects with Mild to Moderate Alzheimer's Disease (REFLECT-3) | Prof. Mok CT. Vincent |
| 2006.387 | Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia Study (The ENIGMA II Trial) | Dr. Chan TV Matthew |
| 2006.383 | Use of Midazolam in Breast Lumpectomy Under Local Anesthesia: A Randomized Controlled Trial | Dr. Shum Chung Nin |
| 2006.378 | Effects of Structured Group-Based Reminiscence Therapy on Depressed Elderly in Psychological Well-Being | Ms. Kwan Wai Shan |
| 2006.374 | Effects of HMG-CoA Reductase Inhibitor on Progression of Carotid Intima-Media Thickness and Arterial Stiffness in Rheumatoid Arthritis | Prof. Tam Lai Shan |
| 2006.373 | Evaluation and Control of Allergic Rhinitis IN Patients with Asthma (CARINA) | Prof. Hui SC David |
| 2006.368 | Open-Label Study of Bevacizumab (Avastin_) Plus Taxane Monotherapy or in Combination for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer ATHENA (Avastin THErapy for advaNced bresAst cancer) | Dr. Ho Wing Ming |
| 2006.367 | An Open-Label Expanded Access Study of Lapatinib and Capecitabine Therapy in Subjects with ErbB2 Overexpressing Locally Advanced or Metastatic Breast Cancer | Dr. Ho Wing Ming |
| 2006.366 | Effects of Different Dosages of Intravitreal Bevacizumab (Avastin) in the Treatment of Diabetic Macular Edema: A Randomized Controlled Trial | Prof. Lam Shun Chiu Dennis |
| 2006.365 | Effects of Different Dosages of Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Trial | Dr. Lai Yuk Yau Timothy |
| 2006.355 | A Randomized 2-Arm, Open-Label, Phase II Study of BMS-582664, Administered Orally at A Dose of 800mg Daily or Doxorubicin Administered Intravenously At A Dose of 60 mg/m2 Every 3 Weeks In Patients with Unresectable, Locally Advanced or Metastatic Hepatocellular Carcinoma | Prof. Yeo Winnie |
| 2006.348 | RAISE (RAndomized placebo-controlled ITP Study with Eltrombopag): A Randomized, Double-Blind, Placebo-Controlled Phase III Study, to Evaluate the Efficacy, Safety and Tolerability of Eltrombopag Olamine (SB-497115-GR), A Thrombopoietin Receptor Agonist, Administered for 6 Months As Oral Tablets Once Daily in Adult Subjects with Previously Treated Chronic Idiopathic Thrombocytopenic Purpura (ITP) | Prof. Cheng Gregory |
| 2006.347 | An Open-Label, Multicenter, Randomized Study of Combination Therapy with Oral Telbivudine Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-Positive Patients with Chronic Hepatitis B Who are Lamivudine Resistant | Prof. Chan L.Y. Henry |
| 2006.346 | A Pilot Study to Investigate the Response of IMD-0354 Ointment in Patients with Atopic Dermatitis | Prof. Hon Kam Lun Ellis |
| 2006.345 | A Pilot Study to Investigate the Efficacy and Safety of IMD-1041 in Patients With Type II Diabetes Mellitus | Prof. Brian Tomlinson |
| 2006.342 | A Preliminary Assessment of Safety and Antiviral Activity of Open-Label Entecavir in Subjects with Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials | Dr. Leung W.Y. Nancy |
| 2006.338 | A Multi-Center Phase III Randomized, Double-Blind Placebo-Controlled Study of the Cancer Vaccine Stimuvax_ (L-BLP25 or BLP25 liposome vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects with Unresectable Stage III Disease | Prof. Mok S.K. Tony |
| 2006.333 | Compliance with Osteoporosis Medication Risedronate | Prof. Leung Ping Chung |
| 2006.326 | Validation of Transient Elastography (Fibroscan) with Liver Histology and Morphometry for the Assessment of Liver Fibrosis | Prof. Chan LY Henry |
| 2006.323 | Galantamine for the Treatment of Probable Vascular Dementia or Possible Alzheimer | Dr. Ho Wan Sze Wency |
| 2006.319 | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ -333369 as Adjunctive Therapy in Subjects with Partial Onset Seizures Followed by an Open-Label Extension Study | Dr. Kwan Patrick |
| 2006.318 | Randomized, Double-Blind Trial Comparing the Effects of A 3-Month Clopidogrel Regimen, Combined with ASA during the First Month, Versus ASA Alone for the Acute Treatment of Patients with TIA or Minor Stroke CASTIA-Clopidogrel in Acute Stroke and TIA | Dr. Leung Wai Hong Thomas |
| 2006.317 | A Phase 2, 12-Week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of A Range of SCH 420814 Doses (1mg BID, 2mg BID, 5mg BID, and Possibly 10mg BID) in Subjects with Moderate to Severe Parkinson | Dr. Mok C.T. Vincent |
| 2006.312 | A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects with Type 2 Diabetes Mellitus | Prof. Ko Tin Choi Gary |
| 2006.311 | GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets | Prof. Clive Stewart Cockram |
| 2006.310 | Phase 2 Study of SU011248 in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma | Prof. Chan T.C. Anthony |
| 2006.309 | Early Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis (ESASIS) | Dr. LEUNG Thomas Wai Hong |
| 2006.308 | A Randomized Controlled Trial of Identifying Predictors of Poor Bowel Preparation in the Elderly (BP Study) | Prof. Lee Yuk Tong |
| 2006.307 | Open Label Study of bevacizumab (AVASTIN_) in Combination with Platinum Containing Chemotherapy as First Line Treatment of Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer (SAIL-Safety of Avastin In Lung) | Prof. Mok Tony |
| 2006.306 | The Use of Ketorolac in Reducing Seroma Formation After Modified Radical Mastectomy: A Randomized Placebo Controlled Trial | Dr. Poon Chi Ming |
| 2006.305 | A Randomized Controlled Trial on the Use of Abdominal Pressure in Colonoscopy | Dr. Poon Chi Ming |
| 2006.304 | A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurkinin-1 Receptor Antagonist, Casopitant (GW679769) in Combination with Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy | Prof. Yeo Winnie |
| 2006.303 | A Phase III, International, Randomised, Double-Blind, Parallel-Group, Multi-Centre Study to Assess the Efficacy of ZD6474 (ZACTIMA | Prof. Mok S.K. Tony |
| 2006.300 | Randomized Trial Comparing Alfuzosin GITS 10mg Daily With Placebo With Long Term Follow Up After Successful Trial Without Catheter in Acute Urinary Retention | Dr. Ng Chi Fai |
| 2006.291 | Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients: A Randomized Control Trial | Prof. Szeto C.C. |
| 2006.287 | A Prospective Double Blinded Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Diseases Among Chinese Patients | Prof. CHIU Philip Wai Yan |
| 2006.286 | EXTEND (Eltrombopag eXTENded Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, with Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in An Eltrombopag Study | Prof. WONG Raymond Siu Ming |
| 2006.283 | Herbs and Rehabilitation After Stroke Study | Prof. Wong Ka Sing Lawrence |
Page 250 of 263.